With the use of artificial intelligence, scientists in Canada and the United States have discovered an antibiotic that could be used to fight a deadly, drug-resistant pathogen and they hope to employ a similar process to discover treatments for other challenging bacteria.
Researchers from the biotechnology company Integrated Biosciences have published a new study in the May issue of Nature Aging showcasing the potential of artificial intelligence (AI) to identify new senolytic compounds. These compounds are a group of small molecules that are being researched for their ability to hinder age-related processes…
The power of artificial intelligence (AI) to find out novel senolytic compounds, a class of small molecules under intense study for their potential to suppress age-related processes like inflammation, fibrosis, and cancer has been illustrated.
The team from the Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard, described the AI-guided screening of more than 800,000 compounds to reveal three drug candidates with comparable efficacy and superior medicinal chemistry properties than those currently under investigation.